Matt Trupo, Richard Jaenisch, and Brian Drapeau explore how AI advances biological insights, drug-target discovery, and supply chains.
Richard Jaenisch
Advertisement
Richard Jaenisch is senior director of Education, Outreach, and Digital Experience at Open Biopharma Research and Training Institute.
Articles by Richard Jaenisch
Industry experts from Sanofi, GxP Frame, and Open Biopharma outline how AI is transforming drug discovery, manufacturing, and workforce strategy through biopharma partnerships in the latest episode of Drug Digest.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on BioPharm International
1
FDA Finalizes Potency Assurance Guidance for Cell and Gene Therapies
2
Shilpa CDMO Commits $50 Million to Scale Peptide Capacity in India
3
Lonza to Acquire Merck KGaA’s US CDMO Business, Adding ADC, Viral Vector, and LNP Capacity
4
Teva Licenses US Rights to Samsung Bioepis TNF Inhibitor Biosimilars
5